Northwest Biotherapeutics Inc. Registered Shares DL -,001

WKN A1J5EY ISIN US66737P6007

Quote/Chart

  • Bid

    -

    0 Units

  • Ask

    -

    0 Units

  • Change compared with previous day (price)

    -0.02 / -4.48 %

  • Spread (Act/ Rel)

    - / -

  • Today's high (Price)

    0.43

  • Today's low (Price)

    0.426

Facts & figures

Price data

Trade platform Börse Stuttgart (XSTU)  
Last price 0.426 G 0 Units
Price determination time 04/23/2024 / 09:00:35 PM
Daily volume (units) 0
Daily high / low 0.43 0.426
Prev. day's price 0.446 (22.04.)
Change day before -0.02 -4.48 %
52 week high / low 1.02 (25/09) 0.366 (24/08)

Key Figures (in EUR)

2023 2022 2021
Earnings per share -0.05 -0.10 -0.05
Dividends per share 0.00 0.00 0.00
Dividend Yield in % 0.00% 0.00% 0.00%
Dividend growth in % - - -
Price - Earnings ratio - - -
Price - Book ratio - - -
Price - Sales ratio 406.08 473.52 702.00
Price - Cash Flow Ratio - - -

Master Data

WKN
A1J5EY
ISIN
US66737P6007
Symbol
NBYB
Exchange segment
Open Market
Type of financial instrument
Equity
Denomination
NORTHWEST BIOTHER.DL-,001
Index membership
-
Trading segment
-
Trading hours
08:00:00 - 22:00:00
Trading currency
Euro
Nominal currency
-
Settlement currency
Euro
Sector and industry
Chemical/Pharmaceutical/Health, Biotechnology
Number of shares
-
Market capitalisation
-

Performance overview

1W 1M 3M 6M 1Y 3Y 5Y YTD
Performance -3.46% 3.72% -18.91% -27.48% 5.19% -60.18% 78.40% -29.21%
High 0.51 0.56 0.62 0.86 1.02 2.18 2.18 0.64
Low 0.43 0.42 0.42 0.42 0.37 0.37 0.12 0.42

Company profile

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.